AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 9448650 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral stimulation on the intact side
Number of subjects: 0
Study 7875638 — intervention group
Group type: EXPERIMENTAL
Intervention: Pinacidil (25 mg, sustained-release form)
Number of subjects: 6
Study 7875638 — intervention group
Group type: EXPERIMENTAL
Intervention: Pinacidil-N-oxide (PO)
Number of subjects: 6
Study 3277476 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical antibiotics alone (22 patients)
Number of subjects: 69
Study 3277476 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefoxitin and topical antibiotics (24 patients)
Number of subjects: 69
Study 3277476 — intervention group
Group type: EXPERIMENTAL
Intervention: Penicillin, tobramycin, clindamycin, and topical antibiotics (23 patients)
Number of subjects: 69
Study 29309346 — intervention group
Group type: EXPERIMENTAL
Intervention: Detectable UPLC (≥25 to <1000 μg/l)
Number of subjects: 517
Study 29309346 — intervention group
Group type: EXPERIMENTAL
Intervention: Undetectable UPLC (<25 μg/l)
Number of subjects: 517
Study 29309346 — intervention group
Group type: EXPERIMENTAL
Intervention: Suboptimal UPLC (≥25 to <1000 μg/l)
Number of subjects: 517
Study 27769201 — intervention group
Group type: EXPERIMENTAL
Intervention: Ecological momentary assessment (EMA) of mood and retrospective questionnaire (CES-D)
Number of subjects: 160
Study 27769201 — intervention group
Group type: EXPERIMENTAL
Intervention: Ecological momentary assessment (EMA) of energy levels and retrospective questionnaire (CES-D)
Number of subjects: 160
Study 27769201 — intervention group
Group type: COMPARATOR
Intervention: Control group completing only the retrospective questionnaire (CES-D)
Number of subjects: 160
Study 24237037 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualised dosing of azathioprine (AZA) starting at 1.0 mg/kg/day (if intermediate TPMT) or 2.5 mg/kg/day (if normal TPMT), adjusted to target 6TGN concentrations of 250-400 pmol/8 × 10(8) RBC.
Number of subjects: 50
Study 24237037 — intervention group
Group type: COMPARATOR
Intervention: Weight-based dosing of azathioprine (AZA) at 2.5 mg/kg/day.
Number of subjects: 50
Study 24237037 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualised dosing of azathioprine (AZA) in per-protocol analysis.
Number of subjects: 50
Study 24237037 — intervention group
Group type: COMPARATOR
Intervention: Weight-based dosing of azathioprine (AZA) in per-protocol analysis.
Number of subjects: 50
Study 24047060 — intervention group
Group type: EXPERIMENTAL
Intervention: Annual screening with fecal occult-blood testing
Number of subjects: 46551
Study 24047060 — intervention group
Group type: EXPERIMENTAL
Intervention: Biennial screening with fecal occult-blood testing
Number of subjects: 46551
Study 24047060 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 46551
Study 20447205 — intervention group
Group type: EXPERIMENTAL
Intervention: Peroral pancreatoscopy (PPS) using a small-diameter videoscope and narrow-band imaging (NBI)
Number of subjects: 21
Study 19083413 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased intake of dietary fiber from fruits/vegetables
Number of subjects: 80
Study 19083413 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased intake of vegetables
Number of subjects: 80
Study 19083413 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased intake of fruits
Number of subjects: 80
Study 19083413 — intervention group
Group type: EXPERIMENTAL
Intervention: Increase of 100 g/d of vegetables
Number of subjects: 80
Study 19083413 — intervention group
Group type: EXPERIMENTAL
Intervention: Increase of 100 g/d of fruits
Number of subjects: 80
Study 16822123 — intervention group
Group type: EXPERIMENTAL
Intervention: Illusory word paradigm with neighbor‐once‐removed similarity contexts
Number of subjects: 0
Study 16822123 — intervention group
Group type: EXPERIMENTAL
Intervention: Masked form priming technique with a lexical‐decision task
Number of subjects: 0
Study 11939988 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 36
Study 11939988 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol plus 'three‐in‐one' block
Number of subjects: 36
Study 11939988 — intervention group
Group type: EXPERIMENTAL
Intervention: Etomidate
Number of subjects: 36
Study 9716765 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm CO2 pneumoperitoneum (37 degrees C)
Number of subjects: 26
Study 9716765 — intervention group
Group type: COMPARATOR
Intervention: Cool CO2 pneumoperitoneum (room temperature)
Number of subjects: 26
Study 7977150 — intervention group
Group type: EXPERIMENTAL
Intervention: High stearic acid diet (7.3% of energy)
Number of subjects: 10
Study 7977150 — intervention group
Group type: EXPERIMENTAL
Intervention: Low stearic acid diet (1.6% of energy)
Number of subjects: 10
Study 3068604 — intervention group
Group type: EXPERIMENTAL
Intervention: Threshold-related, eccentricity-compensated, spatially adaptive suprathreshold screening program
Number of subjects: 157
Study 3068604 — intervention group
Group type: COMPARATOR
Intervention: Full-threshold program on the Humphrey field analyzer
Number of subjects: 157
Study 31898319 — intervention group
Group type: EXPERIMENTAL
Intervention: Bortezomib, cyclophosphamide, dexamethasone (VCD)
Number of subjects: 155
Study 31898319 — intervention group
Group type: COMPARATOR
Intervention: Lenalidomide, cyclophosphamide, dexamethasone (RCD)
Number of subjects: 155
Study 30508643 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D status (measured as serum 25-hydroxyvitamin D concentration)
Number of subjects: 5110
Study 28131393 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-week immune response levels of biomarkers
Number of subjects: 201
Study 28131393 — intervention group
Group type: EXPERIMENTAL
Intervention: Demographic information and two-week response levels of different biomarkers
Number of subjects: 201
Study 23977821 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-based coping skills training
Number of subjects: 162
Study 21362332 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal injection of bevacizumab (1.25 mg/0.05 ml)
Number of subjects: 40
Study 21362332 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal bevacizumab (1.25 mg/0.05 ml) combined with triamcinolone acetonide (2 mg/0.05 ml)
Number of subjects: 40
Study 18950770 — intervention group
Group type: EXPERIMENTAL
Intervention: Perindopril 8 mg/day
Number of subjects: 1157
Study 18950770 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1157
Study 17201798 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose hormone replacement therapy (HRT) with continuous oral 17beta oestradiol (1 mg) and norethisterone (0.5 mg)
Number of subjects: 28
Study 17201798 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 17201798 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose hormone replacement therapy (HRT)
Number of subjects: 28
Study 15138953 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral olanzapine (10 mg per day, increased to 20 mg per day by day 3)
Number of subjects: 0
Study 15138953 — intervention group
Group type: COMPARATOR
Intervention: Oral haloperidol (10 mg per day)
Number of subjects: 0
Study 11499458 — intervention group
Group type: EXPERIMENTAL
Intervention: Short instruction 'What might this be?'
Number of subjects: 60
Study 11499458 — intervention group
Group type: COMPARATOR
Intervention: Long instruction (Killingmo, 1980)
Number of subjects: 60
Study 9972673 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose bedtime NPH insulin
Number of subjects: 50
Study 9972673 — intervention group
Group type: EXPERIMENTAL
Intervention: t.i.d. oral metformin
Number of subjects: 50
Study 8000960 — intervention group
Group type: EXPERIMENTAL
Intervention: Tap water consumption
Number of subjects: 79
Study 8000960 — intervention group
Group type: COMPARATOR
Intervention: Water treated by reverse-osmosis units
Number of subjects: 79
Study 8000960 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall seroprevalence of Norwalk virus
Number of subjects: 79
Study 2782649 — intervention group
Group type: EXPERIMENTAL
Intervention: Halothane (1.7 MAC)
Number of subjects: 18
Study 2782649 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane (1.7 MAC)
Number of subjects: 18
Study 2782649 — intervention group
Group type: EXPERIMENTAL
Intervention: Droperidol
Number of subjects: 18
Study 5321762 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoniazid (5-10 mg per kg of body-weight in one daily dose)
Number of subjects: 0
Study 5321762 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 31954775 — intervention group
Group type: EXPERIMENTAL
Intervention: Dermatophagoides pteronyssinus
Number of subjects: 100
Study 31954775 — intervention group
Group type: EXPERIMENTAL
Intervention: Protease-inactivated Dermatophagoides pteronyssinus
Number of subjects: 100
Study 31954775 — intervention group
Group type: COMPARATOR
Intervention: PBS
Number of subjects: 100
Study 31954775 — intervention group
Group type: EXPERIMENTAL
Intervention: Human breast milk with Der p 1 and/or OVA
Number of subjects: 100
Study 31094438 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Dads Healthy Kids (HDHK) intervention delivered by trained facilitators
Number of subjects: 495
Study 28653963 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupressure
Number of subjects: 79
Study 28653963 — intervention group
Group type: COMPARATOR
Intervention: Sham Acupressure
Number of subjects: 79
Study 28653963 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 79
Study 25961145 — intervention group
Group type: EXPERIMENTAL
Intervention: End-of-treatment self-efficacy
Number of subjects: 1328
Study 23646342 — intervention group
Group type: EXPERIMENTAL
Intervention: Er:YAG laser at 1.6 W
Number of subjects: 100
Study 23646342 — intervention group
Group type: EXPERIMENTAL
Intervention: Er:YAG laser at 2 W
Number of subjects: 100
Study 23646342 — intervention group
Group type: EXPERIMENTAL
Intervention: Er:YAG laser at 3.2 W
Number of subjects: 100
Study 23646342 — intervention group
Group type: COMPARATOR
Intervention: Hydrofluoric acid (HF)
Number of subjects: 100
Study 21724157 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) applied to contralateral acupoints LI4 and LI10, stimulation 20 minutes prior to and throughout the SETT
Number of subjects: 48
Study 21724157 — intervention group
Group type: EXPERIMENTAL
Intervention: Meditation throughout the whole experimental procedure
Number of subjects: 48
Study 21724157 — intervention group
Group type: COMPARATOR
Intervention: Nontreatment group (control)
Number of subjects: 48
Study 19344620 — intervention group
Group type: EXPERIMENTAL
Intervention: NasoPore (Stryker Canada)
Number of subjects: 30
Study 19344620 — intervention group
Group type: COMPARATOR
Intervention: Merocel (traditional middle meatal spacer)
Number of subjects: 30
Study 16968566 — intervention group
Group type: EXPERIMENTAL
Intervention: Eszopiclone 2 mg
Number of subjects: 264
Study 16968566 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 264
Study 16972680 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise programs (aerobics, resistance training, walking)
Number of subjects: 0
Study 16972680 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobics, resistance training, walking
Number of subjects: 0
Study 16972680 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking
Number of subjects: 0
Study 16972680 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise programs
Number of subjects: 0
Study 12799555 — intervention group
Group type: EXPERIMENTAL
Intervention: Atazanavir 400 mg/saquinavir 1200 mg once daily
Number of subjects: 0
Study 12799555 — intervention group
Group type: EXPERIMENTAL
Intervention: Atazanavir 600 mg/saquinavir 1200 mg once daily
Number of subjects: 0
Study 12799555 — intervention group
Group type: COMPARATOR
Intervention: Ritonavir/saquinavir 400 mg/400 mg twice daily
Number of subjects: 0
Study 10430107 — intervention group
Group type: EXPERIMENTAL
Intervention: 1200 mg saquinavir (Fortovase soft-gel capsule formulation)
Number of subjects: 12
Study 7762534 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation (60 mg, 200,000 IU every 4 months)
Number of subjects: 583
Study 7762534 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 583
Study 2193856 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone (1 x 1 g/day)
Number of subjects: 41
Study 2193856 — intervention group
Group type: COMPARATOR
Intervention: Cefotaxime (3 x 1 g/day)
Number of subjects: 41
Study 307155 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine
Number of subjects: 76
Study 307155 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study 30773747 — intervention group
Group type: EXPERIMENTAL
Intervention: CHM-diet (2% Chinese herbal medicine)
Number of subjects: 6
Study 30773747 — intervention group
Group type: COMPARATOR
Intervention: MH-diet (mixed hay, control)
Number of subjects: 6
Study 28128473 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-articular hyaluronic acid (HA) injections (HAnox-M or BioHA), 3 weekly injections
Number of subjects: 166
Study 28128473 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-articular hyaluronic acid (HA) injections (HAnox-M or BioHA)
Number of subjects: 166
Study 26653260 — intervention group
Group type: EXPERIMENTAL
Intervention: Two sessions of glaucoma educational intervention (60-90 minutes each)
Number of subjects: 165
Study 26653260 — intervention group
Group type: COMPARATOR
Intervention: Normal care
Number of subjects: 165
Study 23856172 — intervention group
Group type: EXPERIMENTAL
Intervention: C+L+ (Caffeine 200mg + Bright light 10,000 lux)
Number of subjects: 12
Study 23856172 — intervention group
Group type: COMPARATOR
Intervention: C‐L‐ (Caffeine placebo + Bright light placebo <50 lux)
Number of subjects: 12
Study 22235509 — intervention group
Group type: EXPERIMENTAL
Intervention: Lavender essence
Number of subjects: 200
Study 22235509 — intervention group
Group type: COMPARATOR
Intervention: Clinically neutral aromatic material (control)
Number of subjects: 200
Study 19317898 — intervention group
Group type: EXPERIMENTAL
Intervention: Dignity Therapy offered in addition to standard care
Number of subjects: 64
Study 19317898 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 64
Study 16681811 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional antimycotic treatment
Number of subjects: 309
Study 16681811 — intervention group
Group type: EXPERIMENTAL
Intervention: Interventions designed to strengthen the patients' immune response
Number of subjects: 309
Study 16681811 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosocial factors, particularly stress
Number of subjects: 309
Study 16681811 — intervention group
Group type: COMPARATOR
Intervention: Somatic factors
Number of subjects: 309
Study 15058351 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 dB/octave slope
Number of subjects: 0
Study 15058351 — intervention group
Group type: EXPERIMENTAL
Intervention: 4800 dB/octave slope
Number of subjects: 0
Study 15058351 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 dB presentation level
Number of subjects: 0
Study 15058351 — intervention group
Group type: EXPERIMENTAL
Intervention: 45 dB presentation level
Number of subjects: 0
Study 11044758 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin B6
Number of subjects: 2
Study 11044758 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2
Study 9446368 — intervention group
Group type: EXPERIMENTAL
Intervention: Excision with upper esophageal sphincter myotomy
Number of subjects: 39
Study 9446368 — intervention group
Group type: COMPARATOR
Intervention: Diverticulopexy with upper esophageal sphincter myotomy
Number of subjects: 39
Study 8405018 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac dispersible (50 mg)
Number of subjects: 127
Study 8405018 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen (400 mg)
Number of subjects: 127
Study 8405018 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 127
Study 3806488 — intervention group
Group type: EXPERIMENTAL
Intervention: Established treatment for hypertension interrupted by placebo
Number of subjects: 0
Study 3806488 — intervention group
Group type: EXPERIMENTAL
Intervention: High score group
Number of subjects: 0
Study 3806488 — intervention group
Group type: EXPERIMENTAL
Intervention: Low score group
Number of subjects: 0
Study 31081595 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate allopurinol dose escalation to SU target
Number of subjects: 87
Study 31081595 — intervention group
Group type: COMPARATOR
Intervention: Conventional dosing for 1 year followed by dose escalation to target (Control)
Number of subjects: 87
Study 29210625 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum-derived bovine immunoglobulin/protein isolate (SBI) at 2.5 or 5.0 g BID for 4 weeks
Number of subjects: 103
Study 29210625 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum-derived bovine immunoglobulin/protein isolate (SBI) at 2.5 or 5.0 g BID
Number of subjects: 103
Study 29210625 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 103
Study 26612545 — intervention group
Group type: EXPERIMENTAL
Intervention: Roflumilast 500 μg
Number of subjects: 5169
Study 26612545 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5169
Study 26612545 — intervention group
Group type: EXPERIMENTAL
Intervention: Roflumilast
Number of subjects: 5169
Study 24050581 — intervention group
Group type: EXPERIMENTAL
Intervention: Kangaroo care (KC)
Number of subjects: 90
Study 24050581 — intervention group
Group type: EXPERIMENTAL
Intervention: Music during kangaroo care (KC)
Number of subjects: 90
Study 24050581 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 90
Study 22035351 — intervention group
Group type: COMPARATOR
Intervention: Rosiglitazone
Number of subjects: 20
Study 22035351 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 19501752 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibre and health information on the product
Number of subjects: 0
Study 19501752 — intervention group
Group type: COMPARATOR
Intervention: No health benefit information
Number of subjects: 0
Study 16768603 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress during consolidation
Number of subjects: 157
Study 16768603 — intervention group
Group type: COMPARATOR
Intervention: No stress (control)
Number of subjects: 157
Study 16768603 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress during retrieval
Number of subjects: 157
Study 16768603 — intervention group
Group type: EXPERIMENTAL
Intervention: Cortisol measurement
Number of subjects: 157
Study 12619182 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcitonin
Number of subjects: 170
Study 12619182 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate
Number of subjects: 170
Study 12619182 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 170
Study 11340839 — intervention group
Group type: EXPERIMENTAL
Intervention: Participation in the RCT
Number of subjects: 20
Study 9735577 — intervention group
Group type: EXPERIMENTAL
Intervention: Pure self-help (PSH)
Number of subjects: 72
Study 9735577 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided self-help (GSH)
Number of subjects: 72
Study 9735577 — intervention group
Group type: COMPARATOR
Intervention: Waiting list (WL) control
Number of subjects: 72
Study 7999809 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular rHuEpo
Number of subjects: 6
Study 7999809 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous rHuEpo
Number of subjects: 6
Study 3259732 — intervention group
Group type: EXPERIMENTAL
Intervention: Autotransfusion of drained mediastinal blood
Number of subjects: 25
Study 3259732 — intervention group
Group type: COMPARATOR
Intervention: Stored blood
Number of subjects: 25
Study 29300256 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% lidocaine gel
Number of subjects: 23
Study 29300256 — intervention group
Group type: COMPARATOR
Intervention: Placebo (5 mL of intraurethral aqueous gel)
Number of subjects: 23
Study 29300256 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 28577105 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg
Number of subjects: 58
Study 28577105 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 40 mg
Number of subjects: 58
Study 28577105 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin therapy
Number of subjects: 58
Study 28577105 — intervention group
Group type: COMPARATOR
Intervention: Control (healthy volunteers)
Number of subjects: 58
Study 25917337 — intervention group
Group type: EXPERIMENTAL
Intervention: High-rate cut-off VT zone > 200 bpm (arm B)
Number of subjects: 203
Study 25917337 — intervention group
Group type: EXPERIMENTAL
Intervention: 60-second delayed therapy in the VT zone 170-199 bpm (arm C)
Number of subjects: 203
Study 25917337 — intervention group
Group type: COMPARATOR
Intervention: Prior AT
Number of subjects: 203
Study 23453785 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic adjustable gastric banding (LAGB)
Number of subjects: 51
Study 23453785 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic Roux-en-Y gastric bypass (LRYGB)
Number of subjects: 51
Study 23453785 — intervention group
Group type: COMPARATOR
Intervention: LRYGB
Number of subjects: 51
Study 23453785 — intervention group
Group type: EXPERIMENTAL
Intervention: LAGB
Number of subjects: 51
Study 21985746 — intervention group
Group type: EXPERIMENTAL
Intervention: Caries preventive package (fluoride varnish twice per year for three years, fluoride toothpaste 1,450 ppm F supplied twice per year, toothbrush supplied twice a year, plus standardised dental health education)
Number of subjects: 1200
Study 21985746 — intervention group
Group type: COMPARATOR
Intervention: Standardised dental health education
Number of subjects: 1200
Study 21985746 — intervention group
Group type: EXPERIMENTAL
Intervention: Caries preventive package
Number of subjects: 1200
Study 19935992 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous adhesiolysis with targeted delivery of lidocaine, 10% hypertonic sodium chloride solution, and non‐particulate Betamethasone.
Number of subjects: 120
Study 19935992 — intervention group
Group type: COMPARATOR
Intervention: Fluoroscopically directed caudal epidural steroid injections with local anesthetic, steroids, and 0.9% sodium chloride solution.
Number of subjects: 120
Study 19935992 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous adhesiolysis
Number of subjects: 120
Study 19935992 — intervention group
Group type: COMPARATOR
Intervention: Fluoroscopically directed caudal epidural steroid injections
Number of subjects: 120